CDNA Competitors & Alternatives
Compare CareDx Inc with similar stocks in the same industry
Diagnostics & Research
CDNA
Main Stock$19.97
Tradestie Score
49
Market Cap
$798.40M
Revenue Growth
0.4%
Analyst Upside
+29.2%
Top Competitors
34 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GRAL
GRAIL, Inc. Common Stock
|
$59.65
|
$2.24B | - | 59 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$12.83
|
$2.22B | - | 55 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$49.17
|
$1.77B | - | 57 | Compare |
|
NEOG
Neogen Corp
|
$8.19
|
$1.26B | - | 50 | Compare |
|
OPK
Opko Health Inc.
|
$1.10
|
$1.23B | - | 56 | Compare |
|
NEO
NeoGenomics, Inc.
|
$8.24
|
$1.13B | - | 54 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$19.13
|
$667.77M | - | 52 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$6.36
|
$612.76M | - | 63 | Compare |
|
ARCT
Arcturus Therapeutics Holdings Inc. Common Stock
|
$7.47
|
$556.12M | - | 53 | Compare |
|
FATE
Fate Therapeutics, Inc.
|
$1.76
|
$144.16M | - | 56 | Compare |
More CDNA Analysis
Data updated: May 18, 2026 | Industry: Diagnostics & Research (SIC 8071)
34 stocks in this industry